FDA Person
FDAWei Wang
View detailed information about Wei Wang, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 13 inspections of 13 companies, 2017–2025.
Inspections (13)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| April 24, 2025 | Replimune, Inc. | Not classified | #1275618 | |
| March 26, 2025 | Replimune Limited | Not classified | #1273825 | |
| October 18, 2024 | Bavarian Nordic Berna GmbH | Not classified | #1260537 | |
| September 19, 2024 | Grand River Aseptic Manufacturing, Inc. | Not classified | #1256172 | |
| September 5, 2024 | EdgeOne Medical Inc | Not classified | #1258303 | |
| June 28, 2024 | Pfizer Manufacturing Belgium NV | Not classified | #1240714 | |
| August 25, 2023 | Charles River Laboratories Inc | Not classified | #1223136 | |
| February 8, 2019 | Novartis Gene Therapies, Inc. | Not classified | #1086650 | |
| February 23, 2018 | Symbiosis Pharmaceutical Services Limited | Not classified | #1045937 | |
| February 16, 2018 | Oxford Biomedica (UK) Limited | Not classified | #1050335 | |
| June 22, 2017 | SAFC Carlsbad Inc. | Not classified | #1029623 | |
| June 16, 2017 | Kite Pharma, Inc. | Not classified | #1015808 | |
| February 10, 2017 | Grifols Therapeutics LLC | Not classified | #1003199 |
Documents (8)
- EIR · Pfizer Manufacturing Belgium NV · June 28, 2024
- EIR · Lonza Houston, Inc · February 18, 2022
- 483 · Grand River Aseptic Manufacturing, Inc. · September 19, 2024
- 483 · Novartis Gene Therapies, Inc.
- 483 · Charles River Laboratories Inc · August 25, 2023
- 483 · Krystal Biotech, Inc. · November 16, 2022
- 483 · Replimune Limited
- 483 · Replimune, Inc.
Frequently inspected with (10)
Andrew P. Byrnes
3 shared
Donald B. Ertel
3 shared
Arie Menachem
2 shared
Christine Harman
2 shared
Michael B. Havert
2 shared
Angela S. Whatley
1 shared
Bo Liang
1 shared
Bradley J. Dworak
1 shared
Burnell M. Henry
Investigator
1 shared
Carla A. Lorenzo
1 shared
Person Information
Name
Wei Wang
Title
investigator
Role
COMPANY REP
ID: 943039ac-3917-4d32-9f58-1886c56aecdd
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.